| abstract |
The present disclosure provides compositions and methods for use in the treatment of pain, wherein the compounds useful in such compositions and methods inhibit activity of transient receptor potential cation channel subfamily V member 1 (TRPV1) transcription factors, which in some embodiments may be administered in combination with a compound that modulates the activity of TRPV1. |